Abstract
Recent advances in the field of nanotechnology have allowed the manufacturing of elaborated nanometer-sized particles for various biomedical applications. A broad spectrum of particles, extending from various lipid nanostructures such as liposomes and solid lipid nanoparticles, to metal, nanocrystalline and polymer particles have already been tested as drug delivery systems in different animal models with remarkable results, promising an extensive commercialization in the coming years. Controlled drug release to skin and skin appendages, targeting of hair follicle-specific cell populations, transcutaneous vaccination and transdermal gene therapy are only a few of these new applications. Carrier systems of the new generation take advantage of improved skin penetration properties, depot effect with sustained drug release and of surface functionalization (e.g., the binding to specific ligands) allowing specific cellular and subcellular targeting. Drug delivery to skin by means of microparticles and nanocarriers could revolutionize the treatment of several skin disorders. However, the toxicological and environmental safety of micro- and nanoparticles has to be evaluated using specific toxicological studies prior to a wider implementation of the new technology. This review aims to give an overview of the most investigated applications of transcutaneously applied particle-based formulations in the fields of cosmetics and dermatology.
Similar content being viewed by others
Abbreviations
- APC:
-
Antigen-presenting cells
- BSI:
-
British Standards Institution
- CSSS:
-
Cyanoacrylate skin surface stripping
- DDS:
-
Drug delivery system
- EGFR:
-
Epidermal growth factor receptor
- HBV:
-
Hepatitis B virus
- HIV:
-
Human immunodeficiency virus
- HPV:
-
Human papillomavirus
- ISCOM:
-
Immune stimulating complexes
- LC:
-
Langerhans cells
- MHC:
-
Major histocompatibility complex
- MRI:
-
Magnetic resonance imaging
- P(CL):
-
Poly(ε-caprolactone)
- PDT:
-
Photodynamic therapy
- PLA:
-
Poly-lactic acid
- PLGA:
-
Poly(lactic-co-glycolic) acid
- PS:
-
Polystyrene
- PTT:
-
Photothermal therapy
- QD:
-
Quantum dots
- RSV:
-
Respiratory syncytial virus
- SLN:
-
Solid lipid nanoparticles
- SPF:
-
Sunscreen protection factor
- UV:
-
Ultraviolet
References
Agrawal A, Tripp RA, Anderson LJ, Nie S (2005) Real-time detection of virus particles and viral protein expression with two-color nanoparticle probes. J Virol 79:8625–8628
Ali MF, Salah M, Rafea M, Saleh N (2008) Liposomal methotrexate hydrogel for treatment of localized psoriasis: preparation, characterization and laser targeting. Med Sci Monit 14(12):PI66–PI74
Allen NS, Edge M, Sandoval G, Verran J, Stratton J, Maltby J (2005) Photocatalytic coatings for environmental applications. Photochem Photobiol 81:279–290
Alvarez-Roman R, Barre G, Guy RH, Fessi H (2001) Biodegradable polymer nanocapsules containing a sunscreen agent: preparation and photoprotection. Eur J Pharm Biopharm 52:191–195
Alvarez-Roman R, Naik A, Kalia YN, Guy RH, Fessi H (2004) Enhancement of topical delivery from biodegradable nanoparticles. Pharm Res 21:1818–1825
Alvarez-Roman R, Naik A, Kalia YN, Guy RH, Fessi H (2004) Skin penetration and distribution of polymeric nanoparticles. J Control Release 99:53–62
Alves MP, Scarrone AL, Santos M, Pohlmann AR, Guterres SS (2007) Human skin penetration and distribution of nimesulide from hydrophilic gels containing nanocarriers. Int J Pharm 341:215–220
Apopa PL, Qian Y, Shao R, Guo NL, Schwegler-Berry D, Pacurari M, Porter D, Shi X, Vallyathan V, Castranova V, Flynn DC (2009) Iron oxide nanoparticles induce human microvascular endothelial cell permeability through reactive oxygen species production and microtubule remodeling. Part Fibre Toxicol 6:1
Ataman-Onal Y, Munier S, Ganee A, Terrat C, Durand PY, Battail N, Martinon F, Le GR, Charles MH, Delair T, Verrier B (2006) Surfactant-free anionic PLA nanoparticles coated with HIV-1 p24 protein induced enhanced cellular and humoral immune responses in various animal models. J Control Release 112:175–185
Badea I, Wettig S, Verrall R, Foldvari M (2007) Topical non-invasive gene delivery using gemini nanoparticles in interferon-gamma-deficient mice. Eur J Pharm Biopharm 65:414–422
Ballou B, Ernst LA, Andreko S, Harper T, Fitzpatrick JA, Waggoner AS, Bruchez MP (2007) Sentinel lymph node imaging using quantum dots in mouse tumor models. Bioconjug Chem 18:389–396
Baroli B, Ennas MG, Loffredo F, Isola M, Pinna R, Lopez-Quintela MA (2007) Penetration of metallic nanoparticles in human full-thickness skin. J Invest Dermatol 127:1701–1712
Barton C (2009) Description: nano-enabled delivery. In: Nanotechnology: players, products & prospects to 2018 (Volume II) Espicom Business Intelligence Ltd, http://www.researchandmarkets.com/reports/1210378/ Accessed June 2009
Bernard E, Dubois JL, Wepierre J (1997) Importance of sebaceous glands in cutaneous penetration of an antiandrogen: target effect of liposomes. J Pharm Sci 86:573–578
Bhaskar K, Krishna MC, Lingam M, Jagan MS, Venkateswarlu V, Madhusudan RY, Bhaskar K, Anbu J, Ravichandran V (2009) Development of SLN and NLC enriched hydrogels for transdermal delivery of nitrendipine: in vitro and in vivo characteristics. Drug Dev Ind Pharm 35:98–113
Bikowski J, Del Rosso JQ (2008) Benzoyl peroxide microsphere cream as monotherapy and combination treatment of acne. J Drugs Dermatol 7:590–595
Blume-Peytavi U, Massoudy L, Patzelt A, Lademann J, Dietz E, Rasulev U, Garcia Bartels N (2010) Follicular and percutaneous penetration pathways of topically applied minoxidil foam. Eur J Pharm Biopharm 76(3):450–453
Borm PJ, Robbins D, Haubold S, Kuhlbusch T, Fissan H, Donaldson K, Schins R, Stone V, Kreyling W, Lademann J, Krutmann J, Warheit D, Oberdorster E (2006) The potential risks of nanomaterials: a review carried out for ECETOC. Part Fibre Toxicol 3:11
Castro GA, Coelho AL, Oliveira CA, Mahecha GA, Orefice RL, Ferreira LA (2009) Formation of ion pairing as an alternative to improve encapsulation and stability and to reduce skin irritation of retinoic acid loaded in solid lipid nanoparticles. Int J Pharm 381:77–83
Castro GA, Oliveira CA, Mahecha GA, Ferreira LA. (2011) Comedolytic effect and reduced skin irritation of a new formulation of all-trans retinoic acid-loaded solid lipid nanoparticles for topical treatment of acne. Arch Dermatol Res. doi:10.1007/s00403-011-1130-3
Chatterjee DK, Fong LS, Zhang Y (2008) Nanoparticles in photodynamic therapy: an emerging paradigm. Adv Drug Deliv Rev 60:1627–1637
Chen H, Chang X, Du D, Liu W, Liu J, Weng T, Yang Y, Xu H, Yang X (2006) Podophyllotoxin-loaded solid lipid nanoparticles for epidermal targeting. J Control Release 110:296–306
Chen H, Kim S, He W, Wang H, Low PS, Park K, Cheng JX (2008) Fast release of lipophilic agents from circulating PEG-PDLLA micelles revealed by in vivo forster resonance energy transfer imaging. Langmuir 24:5213–5217
Chen X, Schluesener HJ (2008) Nanosilver: a nanoproduct in medical application. Toxicol Lett 176:1–12
Chirico F, Fumelli C, Marconi A, Tinari A, Straface E, Malorni W, Pellicciari R, Pincelli C (2007) Carboxyfullerenes localize within mitochondria and prevent the UVB-induced intrinsic apoptotic pathway. Exp Dermatol 16:429–436
Combadiere B, Mahe B (2008) Particle-based vaccines for transcutaneous vaccination. Comp Immunol Microbiol Infect Dis 31:293–315
Cross SE, Innes B, Roberts MS, Tsuzuki T, Robertson TA, McCormick P (2007) Human skin penetration of sunscreen nanoparticles: in vitro assessment of a novel micronized zinc oxide formulation. Skin Pharmacol Physiol 20:148–154
Cruz LJ, Tacken PJ, Fokkink R, Joosten B, Stuart MC, Albericio F, Torensma R, Figdor CG (2010) Targeted PLGA nano- but not microparticles specifically deliver antigen to human dendritic cells via DC-SIGN in vitro. J Control Release 144:118–126
de Fine Olivarius F, Hansen AB, Karlsmark T, Wulf HC (1996) Water protective effect of barrier creams and moisturizing creams: a new in vivo test method. Contact Dermatitis 35:219–225
de Vries JJ, Bungener L, Ter VW, van AL, van der LP, Wilschut J, Huckriede A (2009) Incorporation of LpxL1, a detoxified lipopolysaccharide adjuvant, in influenza H5N1 virosomes increases vaccine immunogenicity. Vaccine 27:947–955
Dickerson EB, Dreaden EC, Huang X, El-Sayed IH, Chu H, Pushpanketh S, McDonald JF, El-Sayed MA (2008) Gold nanorod assisted near-infrared plasmonic photothermal therapy (PPTT) of squamous cell carcinoma in mice. Cancer Lett 269:57–66
Dodd NJ, Jha AN (2009) Titanium dioxide induced cell damage: a proposed role of the carboxyl radical. Mutat Res 660:79–82
Donaldson K, Stone V, Clouter A, Renwick L, MacNee W (2001) Ultrafine particles. Occup Environ Med 58:211–216
Durand L, Habran N, Henschel V, Amighi K (2010) Encapsulation of ethylhexyl methoxycinnamate, a light-sensitive UV filter, in lipid nanoparticles. J Microencapsul 27(8):714–725
Egbaria K, Ramachandran C, Weiner N (1991) Topical application of liposomally entrapped cyclosporin evaluated by in vitro diffusion studies with human skin. Skin Pharmacol 4:21–28
El-Sayed IH, Huang X, El-Sayed MA (2006) Selective laser photo-thermal therapy of epithelial carcinoma using anti-EGFR antibody conjugated gold nanoparticles. Cancer Lett 239:129–135
Erdogan M, Wright JR Jr, McAlister VC (2002) Liposomal tacrolimus lotion as a novel topical agent for treatment of immune-mediated skin disorders: experimental studies in a murine model. Br J Dermatol 146:964–967
Fang JY, Fang CL, Liu CH, Su YH (2008) Lipid nanoparticles as vehicles for topical psoralen delivery: solid lipid nanoparticles (SLN) versus nanostructured lipid carriers (NLC). Eur J Pharm Biopharm 70:633–640
Foged C, Brodin B, Frokjaer S, Sundblad A (2005) Particle size and surface charge affect particle uptake by human dendritic cells in an in vitro model. Int J Pharm 298:315–322
Gonzalez S, Fernandez-Lorente M, Gilaberte-Calzada Y (2008) The latest on skin photoprotection. Clin Dermatol 26:614–626
Graf C, Meinke M, Gao Q, Hadam S, Raabe J, Sterry W, Blume-Peytavi U, Lademann J, Ruhl E, Vogt A (2009) Qualitative detection of single submicron and nanoparticles in human skin by scanning transmission X-ray microscopy. J Biomed Opt 14:021015
Gref R, Couvreur P, Barratt G, Mysiakine E (2003) Surface-engineered nanoparticles for multiple ligand coupling. Biomaterials 24:4529–4537
Gulson B, McCall M, Korsch M, Gomez L, Casey P, Oytam Y, Taylor A, McCulloch M, Trotter J, Kinsley L, Greenoak G (2010) Small amounts of zinc from zinc oxide particles in sunscreens applied outdoors are absorbed through human skin. Toxicol Sci 118(1):140–149
Harbarth S, Pittet D, Grady L, Zawacki A, Potter-Bynoe G, Samore MH, Goldmann DA (2002) Interventional study to evaluate the impact of an alcohol-based hand gel in improving hand hygiene compliance. Pediatr Infect Dis J 21:489–495
Henderson BW, Dougherty TJ (1992) How does photodynamic therapy work? Photochem Photobiol 55:145–157
Higaki M, Kameyama M, Udagawa M, Ueno Y, Yamaguchi Y, Igarashi R, Ishihara T, Mizushima Y (2006) Transdermal delivery of CaCO3-nanoparticles containing insulin. Diabetes Technol Ther 8:369–374
Hoffman AS (2008) The origins and evolution of “controlled” drug delivery systems. J Control Release 132:153–163
Jacobson GB, Gonzalez–Gonzalez E, Spitler R, Shinde R, Leake D, Kaspar RL, Contag CH, Zare RN (2010) Biodegradable nanoparticles with sustained release of functional siRNA in skin. J Pharm Sci 99(10):4261–4266
Jain KK (2005) Nanotechnology in clinical laboratory diagnostics. Clin Chim Acta 358:37–54
Jain B, Singh B, Katare OP, Vyas SP (2010) Development and characterization of minoxidil-loaded liposomal system for delivery to pilosebaceous units. J Liposome Res 20(2):105–114
Jain S, Jain S, Khare P, Gulbake A, Bansal D, Jain SK (2010) Design and development of solid lipid nanoparticles for topical delivery of an anti-fungal agent. Drug Deliv 17(6):443–451
Jenning V, Gysler A, Schafer-Korting M, Gohla SH (2000) Vitamin A loaded solid lipid nanoparticles for topical use: occlusive properties and drug targeting to the upper skin. Eur J Pharm Biopharm 49:211–218
Jiang SJ, Chen JY, Lu ZF, Yao J, Che DF, Zhou XJ (2006) Biophysical and morphological changes in the stratum corneum lipids induced by UVB irradiation. J Dermatol Sci 44:29–36
Jung S, Otberg N, Thiede G, Richter H, Sterry W, Panzner S, Lademann J (2006) Innovative liposomes as a transfollicular drug delivery system: penetration into porcine hair follicles. J Invest Dermatol 126:1728–1732
Kainthan RK, Gnanamani M, Ganguli M, Ghosh T, Brooks DE, Maiti S, Kizhakkedathu JN (2006) Blood compatibility of novel water soluble hyperbranched polyglycerol-based multivalent cationic polymers and their interaction with DNA. Biomaterials 27:5377–5390
Kanchan V, Panda AK (2007) Interactions of antigen-loaded polylactide particles with macrophages and their correlation with the immune response. Biomaterials 28:5344–5357
Kato S, Taira H, Aoshima H, Saitoh Y, Miwa N (2010) Clinical evaluation of fullerene-C60 dissolved in squalane for anti-wrinkle cosmetics. J Nanosci Nanotechnol 10(10):6769–6774
Keck CM, Schwabe K (2009) Silver-nanolipid complex for application to atopic dermatitis skin: rheological characterization, in vivo efficiency and theory of action. J Biomed Nanotechnol 5(4):428–436
Khdair A, Chen D, Patil Y, Ma L, Dou QP, Shekhar MP, Panyam J (2010) Nanoparticle-mediated combination chemotherapy and photodynamic therapy overcomes tumor drug resistance. J Control Release 141:137–144
Klaper R, Crago J, Barr J, Arndt D, Setyowati K, Chen J (2008) Toxicity biomarker expression in daphnids exposed to manufactured nanoparticles: changes in toxicity with functionalization. Environ Pollut 157(4):1152–1156
Knorr F, Lademann J, Patzelt A, Sterry W, Blume-Peytavi U, Vogt A (2009) Follicular transport route-research progress and future perspectives. Eur J Pharm Biopharm 71(2):173–180
Kreuter J, Shamenkov D, Petrov V, Ramge P, Cychutek K, Koch-Brandt C, Alyautdin R (2002) Apolipoprotein-mediated transport of nanoparticle-bound drugs across the blood–brain barrier. J Drug Target 10:317–325
Kristl J, Teskac K, Grabnar PA (2010) Current view on nanosized solid lipid carriers for drug delivery to the skin. J Biomed Nanotechnol 6(5):529–542
Kumar R, Singh B, Bakshi G, Katare OP (2007) Development of liposomal systems of finasteride for topical applications: design, characterization, and in vitro evaluation. Pharm Dev Technol 12:591–601
Lademann J, Otberg N, Jacobi U, Hoffman RM, Blume-Peytavi U (2005) Follicular penetration and targeting. J Investig Dermatol Symp Proc 10:301–303
Lademann J, Otberg N, Richter H, Weigmann HJ, Lindemann U, Schaefer H, Sterry W (2001) Investigation of follicular penetration of topically applied substances. Skin Pharmacol Appl Skin Physiol 14(Suppl 1):17–22
Lademann J, Richter H, Golz K, Zastrow L, Sterry W, Patzelt A (2008) Influence of microparticles on the homogeneity of distribution of topically applied substances. Skin Pharmacol Physiol 21:274–282
Lademann J, Richter H, Teichmann A, Otberg N, Blume-Peytavi U, Luengo J, Weiss B, Schaefer UF, Lehr CM, Wepf R, Sterry W (2007) Nanoparticles—an efficient carrier for drug delivery into the hair follicles. Eur J Pharm Biopharm 66:159–164
Lademann J, Rudolph A, Jacobi U, Weigmann HJ, Schaefer H, Sterry W, Meinke M (2004) Influence of nonhomogeneous distribution of topically applied UV filters on sun protection factors. J Biomed Opt 9:1358–1362
Lademann J, Weigmann H, Rickmeyer C, Barthelmes H, Schaefer H, Mueller G, Sterry W (1999) Penetration of titanium dioxide microparticles in a sunscreen formulation into the horny layer and the follicular orifice. Skin Pharmacol Appl Skin Physiol 12:247–256
Larese FF, D’Agostin F, Crosera M, Adami G, Renzi N, Bovenzi M, Maina G (2009) Human skin penetration of silver nanoparticles through intact and damaged skin. Toxicology 255:33–37
Lawson LB, Freytag LC, Clements JD (2007) Use of nanocarriers for transdermal vaccine delivery. Clin Pharmacol Ther 82:641–643
Lboutounne H, Chaulet JF, Ploton C, Falson F, Pirot F (2002) Sustained ex vivo skin antiseptic activity of chlorhexidine in poly(epsilon-caprolactone) nanocapsule encapsulated form and as a digluconate. J Control Release 82:319–334
Lboutounne H, Faivre V, Falson F, Pirot F (2004) Characterization of transport of chlorhexidine-loaded nanocapsules through hairless and wistar rat skin. Skin Pharmacol Physiol 17:176–182
Lekki J, Stachura Z, Dabros W, Stachura J, Menzel F, Reinert T, Butz T, Pallon J, Gontier E, Ynsa MD, Moretto P, Kertesz Z, Szikszai Z, Kiss AZ (2007) On the follicular pathway of percutaneous uptake of nanoparticles: ion microscopy and autoradiography studies. Nucl Instrum Methods Phys Res Sect B 260:174–177
Li N, Xia T, Nel AE (2008) The role of oxidative stress in ambient particulate matter-induced lung diseases and its implications in the toxicity of engineered nanoparticles. Free Radic Biol Med 44:1689–1699
Lin W, Huang YW, Zhou XD, Ma Y (2006) In vitro toxicity of silica nanoparticles in human lung cancer cells. Toxicol Appl Pharmacol 217:252–259
Liu D, Ge Y, Tang Y, Yuan Y, Zhang Q, Li R, Xu Q (2010) Solid lipid nanoparticles for transdermal delivery of diclofenac sodium: preparation, characterization and in vitro studies. J Microencapsul 27(8):726–734
Lu W, Xiong C, Zhang G, Huang Q, Zhang R, Zhang JZ, Li C (2009) Targeted photothermal ablation of murine melanomas with melanocyte-stimulating hormone analog-conjugated hollow gold nanospheres. Clin Cancer Res 15:876–886
Ludwig C, Wagner R (2007) Virus-like particles-universal molecular toolboxes. Curr Opin Biotechnol 18:537–545
Mahe B, Vogt A, Liard C, Duffy D, Abadie V, Bonduelle O, Boissonnas A, Sterry W, Verrier B, Blume-Peytavi U, Combadiere B (2009) Nanoparticle-based targeting of vaccine compounds to skin antigen-presenting cells by hair follicles and their transport in mice. J Invest Dermatol 129:1156–1164
Meidan VM, Bonner MC, Michniak BB (2005) Transfollicular drug delivery—is it a reality? Int J Pharm 306:1–14
Meidan VM (2010) Methods for quantifying intrafollicular drug delivery: a critical appraisal. Expert Opin Drug Deliv 7(9):1095–1108
Michel M, L’Heureux N, Pouliot R, Xu W, Auger FA, Germain L (1999) Characterization of a new tissue-engineered human skin equivalent with hair. In Vitro Cell Dev Biol Anim 35:318–326
Mohamed F, van der Walle CF (2006) PLGA microcapsules with novel dimpled surfaces for pulmonary delivery of DNA. Int J Pharm 311:97–107
Mordon S, Sumian C, Devoisselle JM (2003) Site-specific methylene blue delivery to pilosebaceous structures using highly porous nylon microspheres: an experimental evaluation. Lasers Surg Med 33:119–125
Mortensen LJ, Oberdörster G, Pentland AP, Delouise LA (2008) In vivo skin penetration of quantum dot nanoparticles in the murine model: the effect of UVR. Nano Lett 8:2779–2787
Müller RH, Keck CM (2004) Drug delivery to the brain-realization by novel drug carriers. J Nanosci Nanotechnol 4:471–483
Münster U, Nakamura C, Haberland A, Jores K, Mehnert W, Rummel S, Schaller M, Korting HC, Zouboulis C, Blume-Peytavi U, Schafer-Korting M (2005) RU 58841-myristate-prodrug development for topical treatment of acne and androgenetic alopecia. Pharmazie 60:8–12
Nakagawa Y, Wakuri S, Sakamoto K, Tanaka N (1997) The photogenotoxicity of titanium dioxide particles. Mutat Res 394:125–132
Nakamura M, Jo J, Tabata Y, Ishikawa O (2008) Controlled delivery of T-box21 small interfering RNA ameliorates autoimmune alopecia (alopecia areata) in a C3H/HeJ mouse model. Am J Pathol 172:650–658
Newman MD, Stotland M, Ellis JI (2009) The safety of nanosized particles in titanium dioxide- and zinc oxide-based sunscreens. J Am Acad Dermatol 61:685–692
Nhung DT, Freydiere AM, Constant H, Falson F, Pirot F (2007) Sustained antibacterial effect of a hand rub gel incorporating chlorhexdine-loaded nanocapsules (Nanochlorex). Int J Pharm 334:166–172
Olafsson R, Bauer DR, Montilla LG, Witte RS (2010) Real-time, contrast enhanced photoacoustic imaging of cancer in a mouse window chamber. Opt Express 18(18):18625–18632
O’Reilly RK, Hawker CJ, Wooley KL (2006) Cross-linked block copolymer micelles: functional nanostructures of great potential and versatility. Chem Soc Rev 35:1068–1083
Oberdorster G, Finkelstein JN, Johnston C, Gelein R, Cox C, Baggs R, Elder AC (2000) Acute pulmonary effects of ultrafine particles in rats and mice. Res Rep Health Eff Inst 96:5–74
Otberg N, Richter H, Schaefer H, Blume-Peytavi U, Sterry W, Lademann J (2004) Variations of hair follicle size and distribution in different body sites. J Invest Dermatol 122:14–19
Padamwar MN, Pokharkar VB (2006) Development of vitamin loaded topical liposomal formulation using factorial design approach: drug deposition and stability. Int J Pharm 320:37–44
Panyam J, Labhasetwar V (2003) Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv Drug Deliv Rev 55(3):329–347
Patel VB, Misra A, Marfatia YS (2000) Topical liposomal gel of tretinoin for the treatment of acne: research and clinical implications. Pharm Dev Technol 5:455–464
Peachman KK, Rao M, Alving CR (2003) Immunization with DNA through the skin. Methods 31:232–242
Peek LJ, Middaugh CR, Berkland C (2008) Nanotechnology in vaccine delivery. Adv Drug Deliv Rev 60:915–928
Pinnell SR, Fairhurst D, Gillies R, Mitchnick MA, Kollias N (2000) Microfine zinc oxide is a superior sunscreen ingredient to microfine titanium dioxide. Dermatol Surg 26(4):309–314
Pitsillides CM, Joe EK, Wei X, Anderson RR, Lin CP (2003) Selective cell targeting with light-absorbing microparticles and nanoparticles. Biophys J 84:4023–4032
Prow TW, Grice JE, Lin LL, Faye R, Butler M, Becker W, Wurm EM, Yoong C, Robertson TA, Soyer HP, Roberts MS (2011) Nanoparticles and microparticles for skin drug delivery. Adv Drug Deliv Rev. doi:10.1016/j.addr.2011.01.012
Queille-Roussel C, Poncet M, Mesaros S, Clucas A, Baker M, Soloff AM (2001) Comparison of the cumulative irritation potential of adapalene gel and cream with that of erythromycin/tretinoin solution and gel and erythromycin/isotretinoin gel. Clin Ther 23:205–212
Rancan F, Helmreich M, Molich A, Ermilov EA, Jux N, Roder B, Hirsch A, Bohm F (2007) Synthesis and in vitro testing of a pyropheophorbide-a-fullerene hexakis adduct immunoconjugate for photodynamic therapy. Bioconjug Chem 18:1078–1086
Rancan F, Papakostas D, Hadam S, Hackbarth S, Delair T, Primard C, Verrier B, Sterry W, Blume-Peytavi U, Vogt A (2009) Investigation of polylactic acid (PLA) nanoparticles as drug delivery systems for local dermatotherapy. Pharm Res 26:2027–2036
Rastogi R, Anand S, Koul V (2010) Electroporation of polymeric nanoparticles: an alternative technique for transdermal delivery of insulin. Drug Dev Ind Pharm 36(11):1303–1311
Regehly M, Greish K, Rancan F, Maeda H, Böhm F, Röder B (2007) Water-soluble polymer conjugates of ZnPP for photodynamic tumor therapy. Bioconjug Chem 18(2):494–499
Rockall AG, Sohaib SA, Harisinghani MG, Babar SA, Singh N, Jeyarajah AR, Oram DH, Jacobs IJ, Shepherd JH, Reznek RH (2005) Diagnostic performance of nanoparticle-enhanced magnetic resonance imaging in the diagnosis of lymph node metastases in patients with endometrial and cervical cancer. J Clin Oncol 23:2813–2821
Rolland A, Wagner N, Chatelus A, Shroot B, Schaefer H (1993) Site-specific drug delivery to pilosebaceous structures using polymeric microspheres. Pharm Res 10:1738–1744
Santos MC, Mehnert W, Schaller M, Korting HC, Gysler A, Haberland A, Schafer-Korting M (2002) Drug targeting by solid lipid nanoparticles for dermal use. J Drug Target 10:489–495
Saraswat A, Agarwal R, Katare OP, Kaur I, Kumar B (2007) A randomized, double-blind, vehicle-controlled study of a novel liposomal dithranol formulation in psoriasis. J Dermatolog Treat 18:40–45
Saupe A, Wissing SA, Lenk A, Schmidt C, Muller RH (2005) Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC)–structural investigations on two different carrier systems. Biomed Mater Eng 15:393–402
Schaefer H, Lademann J (2001) The role of follicular penetration. A differential view. Skin Pharmacol Appl Skin Physiol 14(Suppl 1):23–27
Schafer-Korting M, Mehnert W, Korting HC (2007) Lipid nanoparticles for improved topical application of drugs for skin diseases. Adv Drug Deliv Rev 59:427–443
Schlupp P, Blaschke T, Kramer KD, Höltje HD, Mehnert W, Schäfer-Korting M (2011) Drug release and skin penetration from solid lipid nanoparticles and a base cream: a systematic approach from a comparison of three glucocorticoids. Skin Pharmacol Physiol 24(4):199–209
Schwarz K, Storni T, Manolova V, Didierlaurent A, Sirard JC, Rothlisberger P, Bachmann MF (2003) Role of Toll-like receptors in costimulating cytotoxic T cell responses. Eur J Immunol 33:1465–1470
Shakeel F, Ramadan W, Ahmed MA (2009) Investigation of true nanoemulsions for transdermal potential of indomethacin: characterization, rheological characteristics, and ex vivo skin permeation studies. J Drug Target 17:435–441
Shim J, Seok KH, Park WS, Han SH, Kim J, Chang IS (2004) Transdermal delivery of mixnoxidil with block copolymer nanoparticles. J Control Release 97:477–484
Souto EB, Wissing SA, Barbosa CM, Muller RH (2004) Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery. Int J Pharm 278:71–77
Stecová J, Mehnert W, Blaschke T, Kleuser B, Sivaramakrishnan R, Zouboulis CC, Seltmann H, Korting HC, Kramer KD, Schäfer-Korting M. (2007) Cyproterone acetate loading to lipid nanoparticles for topical acne treatment: particle characterisation and skin uptake. Pharm Res 24(5):991–1000
Storni T, Kundig TM, Senti G, Johansen P (2005) Immunity in response to particulate antigen-delivery systems. Adv Drug Deliv Rev 57:333–355
Taglietti M, Hawkins CN, Rao J (2008) Novel topical drug delivery systems and their potential use in acne vulgaris. Skin Therapy Lett 13:6–8
Tamber H, Johansen P, Merkle HP, Gander B (2005) Formulation aspects of biodegradable polymeric microspheres for antigen delivery. Adv Drug Deliv Rev 57:357–376
Tay A, Yang ST (2002) Production of L(+)-lactic acid from glucose and starch by immobilized cells of Rhizopus oryzae in a rotating fibrous bed bioreactor. Biotechnol Bioeng 80:1–12
Tenjarla S (1999) Microemulsions: an overview and pharmaceutical applications. Crit Rev Ther Drug Carrier Syst 16:461–521
Toll R, Jacobi U, Richter H, Lademann J, Schaefer H, Blume-Peytavi U (2004) Penetration profile of microspheres in follicular targeting of terminal hair follicles. J Invest Dermatol 123:168–176
Tsuang YH, Sun JS, Huang YC, Lu CH, Chang WH, Wang CC (2008) Studies of photokilling of bacteria using titanium dioxide nanoparticles. Artif Organs 32:167–174
Tsujimoto H, Hara K, Tsukada Y, Huang CC, Kawashima Y, Arakaki M, Okayasu H, Mimura H, Miwa N (2007) Evaluation of the permeability of hair growing ingredient encapsulated PLGA nanospheres to hair follicles and their hair growing effects. Bioorg Med Chem Lett 17:4771–4777
Ulrich C, Degen A, Patel MJ, Stockfleth E (2008) Sunscreens in organ transplant patients. Nephrol Dial Transplant 23:1805–1808
Van R I (2006) Beyond skin feel: innovative methods for developing complex sensory profiles with silicones. J Cosmet Dermatol 5:61–67
Venuganti VV, Perumal OP (2009) Poly(amidoamine) dendrimers as skin penetration enhancers: Influence of charge, generation, and concentration. J Pharm Sci 98:2345–2356
Verma DD, Verma S, McElwee KJ, Freyschmidt-Paul P, Hoffman R, Fahr A (2004) Treatment of alopecia areata in the DEBR model using Cyclosporin A lipid vesicles. Eur J Dermatol 14:332–338
Villalonga-Barber C, Micha-Screttas M, Steele BR, Georgopoulos A, Demetzos C (2008) Dendrimers as biopharmaceuticals: synthesis and properties. Curr Top Med Chem 8:1294–1309
Vogt A, Combadiere B, Hadam S, Stieler KM, Lademann J, Schaefer H, Autran B, Sterry W, Blume-Peytavi U (2006) 40 nm, but not 750 or 1, 500 nm, nanoparticles enter epidermal CD1a+ cells after transcutaneous application on human skin. J Invest Dermatol 126:1316–1322
Vogt A, Mahe B, Costagliola D, Bonduelle O, Hadam S, Schaefer G, Schaefer H, Katlama C, Sterry W, Autran B, Blume-Peytavi U, Combadiere B (2008) Transcutaneous anti-influenza vaccination promotes both CD4 and CD8 T cell immune responses in humans. J Immunol 180:1482–1489
Vogt A, Mandt N, Lademann J, Schaefer H, Blume-Peytavi U (2005) Follicular targeting—a promising tool in selective dermatotherapy. J Investig Dermatol Symp Proc 10:252–255
Walther C, Meyer K, Rennert R, Neundorf I (2008) Quantum dot-carrier peptide conjugates suitable for imaging and delivery applications. Bioconjug Chem 19:2346–2356
Wamer WG, Yin JJ, Wei RR (1997) Oxidative damage to nucleic acids photosensitized by titanium dioxide. Free Radic Biol Med 23:851–858
Warheit DB, Reed KL, Webb TR (2003) Pulmonary toxicity studies in rats with triethoxyoctylsilane (OTES)-coated, pigment-grade titanium dioxide particles: bridging studies to predict inhalation hazard. Exp Lung Res 29:593–606
Westedt U, Barbu-Tudoran L, Schaper AK, Kalinowski M, Alfke H, Kissel T (2002) Deposition of nanoparticles in the arterial vessel by porous balloon catheters: localization by confocal laser scanning microscopy and transmission electron microscopy. AAPS PharmSci 4:E41
Xia Q, Saupe A, Muller RH, Souto EB (2007) Nanostructured lipid carriers as novel carrier for sunscreen formulations. Int J Cosmet Sci 29:473–482
Xia T, Kovochich M, Brant J, Hotze M, Sempf J, Oberley T, Sioutas C, Yeh JI, Wiesner MR, Nel AE (2006) Comparison of the abilities of ambient and manufactured nanoparticles to induce cellular toxicity according to an oxidative stress paradigm. Nano Lett 6:1794–1807
Yamamoto T, Kurasawa M, Hattori T, Maeda T, Nakano H, Sasaki H (2008) Relationship between expression of tight junction-related molecules and perturbed epidermal barrier function in UVB-irradiated hairless mice. Arch Dermatol Res 300:61–68
Yih TC, Al-Fandi M (2006) Engineered nanoparticles as precise drug delivery systems. J Cell Biochem 97:1184–1190
Zhai H, Maibach HI (2002) Barrier creams-skin protectants: can you protect skin? J Cosmet Dermatol 1:20–23
Zhang J, Smith E (2010) Percutaneous permeation of betamethasone 17-valerate incorporated in lipid nanoparticles. J Pharm Sci 100(3):896–903
Zhou M, Nakatani E, Gronenberg LS, Tokimoto T, Wirth MJ, Hruby VJ, Roberts A, Lynch RM, Ghosh I (2007) Peptide-labeled quantum dots for imaging GPCRs in whole cells and as single molecules. Bioconjug Chem 18:323–332
Related articles recently published in Archives of Dermatological Research (selected by the journal’s editorial staff):
Buraczewska I, Berne B, Lindberg M, Loden M, Torma H (2009) Moisturizers change the mRNA expression of enzymes synthesizing skin barrier lipids. Arch Dermatol Res 301:587–594
Gupta NK, Dixit VK (2011) Development and evaluation of vesicular system for curcumin delivery. Arch Dermatol Res 303:89–101
Author information
Authors and Affiliations
Corresponding author
Additional information
D. Papakostas and F. Rancan contributed equally to this work.
Rights and permissions
About this article
Cite this article
Papakostas, D., Rancan, F., Sterry, W. et al. Nanoparticles in dermatology. Arch Dermatol Res 303, 533–550 (2011). https://doi.org/10.1007/s00403-011-1163-7
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00403-011-1163-7